378 related articles for article (PubMed ID: 22047681)
21. Mirtazapine versus megestrol acetate in treatment of anorexia-cachexia in advanced cancer patients: a randomized, double-blind trial.
Chowdhury IH; Rahman MS; Chowdhury MNK; Afroze YJ; Tabassum M; Marnush M; Zerin N
Jpn J Clin Oncol; 2024 May; 54(5):530-536. PubMed ID: 38323684
[TBL] [Abstract][Full Text] [Related]
22. Treating malnutrition with megestrol acetate: literature review and review of our experience.
Karcic E; Philpot C; Morley JE
J Nutr Health Aging; 2002 May; 6(3):191-200. PubMed ID: 12152625
[TBL] [Abstract][Full Text] [Related]
23. [Supportive treatment with megestrol acetate during radio(chemo)therapy in patients with tumors in the head-neck area. A randomized study].
Fietkau R; Riepl M; Kettner H; Hinke A; Sauer R
Strahlenther Onkol; 1996 Mar; 172(3):162-8. PubMed ID: 8721265
[TBL] [Abstract][Full Text] [Related]
24. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
Gebbia V; Testa A; Gebbia N
Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy.
Mantovani G; Maccio A; Madeddu C; Massa E; Mudu MC; Mulas C; Gramignano G; Massidda S; Murgia V; Lusso MR; Mura L
Int J Oncol; 2001 Feb; 18(2):383-91. PubMed ID: 11172608
[TBL] [Abstract][Full Text] [Related]
26. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia.
Vadell C; Seguí MA; Giménez-Arnau JM; Morales S; Cirera L; Bestit I; Batiste E; Blanco R; Jolis L; Boleda M; Antón I
Am J Clin Oncol; 1998 Aug; 21(4):347-51. PubMed ID: 9708631
[TBL] [Abstract][Full Text] [Related]
27. Megestrol acetate for the treatment of anorexia-cachexia syndrome.
Berenstein EG; Ortiz Z
Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706
[TBL] [Abstract][Full Text] [Related]
28. Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
Loprinzi CL; Bernath AM; Schaid DJ; Malliard JA; Athmann LM; Michalak JC; Tschetter LK; Hatfield AK; Morton RF
Oncology; 1994 Oct; 51 Suppl 1():2-7. PubMed ID: 7970505
[TBL] [Abstract][Full Text] [Related]
29. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia.
Loprinzi CL; Ellison NM; Schaid DJ; Krook JE; Athmann LM; Dose AM; Mailliard JA; Johnson PS; Ebbert LP; Geeraerts LH
J Natl Cancer Inst; 1990 Jul; 82(13):1127-32. PubMed ID: 2193166
[TBL] [Abstract][Full Text] [Related]
30. [Phase II trial evaluating the effect of megestrol acetate-prednisolone combination in the treatment of anorexia during the palliative-care phase of lung cancer].
Jeanfaivre T; Souday V; Chaleil D; Maillet F; Tuchais E
Rev Pneumol Clin; 2000 Sep; 56(4):255-60. PubMed ID: 11033533
[TBL] [Abstract][Full Text] [Related]
31. Low-dose megestrol acetate for appetite stimulation in advanced cancer.
Donnelly S; Walsh TD
J Pain Symptom Manage; 1995 Apr; 10(3):182-3. PubMed ID: 7629410
[No Abstract] [Full Text] [Related]
32. Megestrol acetate: its impact on muscle protein metabolism supports its use in cancer cachexia.
Busquets S; Serpe R; Sirisi S; Toledo M; Coutinho J; Martínez R; Orpí M; López-Soriano FJ; Argilés JM
Clin Nutr; 2010 Dec; 29(6):733-7. PubMed ID: 20621398
[TBL] [Abstract][Full Text] [Related]
33. The Bristol-Myers Anorexia/Cachexia Recovery Instrument (BACRI): a brief assessment of patients' subjective response to treatment for anorexia/cachexia.
Cella DF; VonRoenn J; Lloyd S; Browder HP
Qual Life Res; 1995 Jun; 4(3):221-31. PubMed ID: 7613532
[TBL] [Abstract][Full Text] [Related]
34. [Current views on use of megestrol acetate in oncology practice].
Vyzula R
Vnitr Lek; 1997 Apr; 43(4):250-5. PubMed ID: 9601846
[TBL] [Abstract][Full Text] [Related]
35. [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome].
Krznarić Z; Juretić A; Samija M; Dintinjana RD; Vrdoljak E; Samarzija M; Kolacek S; Vrbanec D; Prgomet D; Ivkić M; Zelić M;
Lijec Vjesn; 2007 Dec; 129(12):381-6. PubMed ID: 18383739
[TBL] [Abstract][Full Text] [Related]
36. Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients.
Mateen F; Jatoi A
Clin Nutr; 2006 Oct; 25(5):711-5. PubMed ID: 16867306
[TBL] [Abstract][Full Text] [Related]
37. Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy.
Greig CA; Johns N; Gray C; MacDonald A; Stephens NA; Skipworth RJ; Fallon M; Wall L; Fox GM; Fearon KC
Support Care Cancer; 2014 May; 22(5):1269-75. PubMed ID: 24389826
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.
Cuvelier GD; Baker TJ; Peddie EF; Casey LM; Lambert PJ; Distefano DS; Wardle MG; Mychajlunow BA; Romanick MA; Dix DB; Wilson BA
Pediatr Blood Cancer; 2014 Apr; 61(4):672-9. PubMed ID: 24167059
[TBL] [Abstract][Full Text] [Related]
39. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms.
Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
Crit Rev Oncog; 1998; 9(2):99-106. PubMed ID: 9973244
[TBL] [Abstract][Full Text] [Related]
40. Megestrol acetate for treatment of anorexia-cachexia syndrome.
Ruiz Garcia V; López-Briz E; Carbonell Sanchis R; Gonzalvez Perales JL; Bort-Marti S
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD004310. PubMed ID: 23543530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
